AnaptysBio, Inc. (ANAB)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | 8-K (2026-05-12) · 99.1 | ||
| 10-K/A | FY-2025 | |||
| 10-KLatest | FY-2025 | 8-K (2026-03-03) · 99.1 · 99.2 | 8-K (2026-01-09) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-04) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-06) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-05) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-02-27) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-05) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-05) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-09) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-11) · 99.1 | 8-K (2024-01-05) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-02) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-07) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Income (loss) | — |
|
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statement of Stockholders Equity (deficit) | — |
|
| Consolidated Statements of Stockholders Equity | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Operations and Comprehensive Loss (P) | ||
| Consolidated Statement of Stockholders Equity (deficit) (P) | — |
|
| Consolidated Statement of Stockholders Equity (P) | ||
| Notes | ||
| Balance Sheet Accounts and Supplemental Disclosures | ||
| Collaborative Research and Development Agreements | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Description of The Business | ||
| Employee Benefit Plan | — |
|
| Equity Incentive Plans | ||
| Fair Value Measurements and Available For Sale Investments | ||
| Fair Value Measurements and Available-for-sale Investments | — |
|
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Pay Vs Performance Disclosure | ||
| Sale of Future Royalties | ||
| Segment Reporting | ||
| Stockholders' Equity | ||
| Subsequent Event | ||
| Summary of Significant Accounting Policies | ||